Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
vaginal yeast infection
Posted inInfections, New Drugs, Regulatory
Brexafemme: New Drug for Vaginal Yeast Infection
Scynexis offered ibrexafungerp, a new antifungal medication for vulvovaginal candidiasis treatment.
